Jasper Therapeutics (JSPRW) Competitors $0.01 0.00 (-10.60%) Closing price 02:06 PM EasternExtended Trading$0.01 0.00 (-0.74%) As of 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock JSPRW vs. AIMDW, ALVOW, ARAV, ACABW, and RNAShould you buy Jasper Therapeutics stock or one of its competitors? MarketBeat compares Jasper Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jasper Therapeutics include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry. JSPRW vs. AIMDWJSPRW vs. ALVOWJSPRW vs. ARAVJSPRW vs. ACABWJSPRW vs. RNAHow does Jasper Therapeutics compare to Ainos?Ainos (NASDAQ:AIMDW) and Jasper Therapeutics (NASDAQ:JSPRW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings. Which has higher earnings & valuation, AIMDW or JSPRW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$18.11KN/AN/AN/AN/AJasper TherapeuticsN/AN/AN/AN/AN/A Is AIMDW or JSPRW more profitable? Company Net Margins Return on Equity Return on Assets AinosN/A N/A N/A Jasper Therapeutics N/A N/A N/A Does the media refer more to AIMDW or JSPRW? In the previous week, Jasper Therapeutics had 3 more articles in the media than Ainos. MarketBeat recorded 4 mentions for Jasper Therapeutics and 1 mentions for Ainos. Ainos' average media sentiment score of 0.00 beat Jasper Therapeutics' score of -0.20 indicating that Ainos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ainos 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jasper Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAinos beats Jasper Therapeutics on 2 of the 3 factors compared between the two stocks.How does Jasper Therapeutics compare to Alvotech?Jasper Therapeutics (NASDAQ:JSPRW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Is JSPRW or ALVOW more profitable? Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A N/A N/A Alvotech N/A N/A N/A Does the media refer more to JSPRW or ALVOW? In the previous week, Jasper Therapeutics had 4 more articles in the media than Alvotech. MarketBeat recorded 4 mentions for Jasper Therapeutics and 0 mentions for Alvotech. Alvotech's average media sentiment score of 0.00 beat Jasper Therapeutics' score of -0.20 indicating that Alvotech is being referred to more favorably in the news media. Company Overall Sentiment Jasper Therapeutics Neutral Alvotech Neutral Which has better valuation and earnings, JSPRW or ALVOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/AN/AN/AN/AAlvotech$586.32MN/AN/AN/AN/A SummaryAlvotech beats Jasper Therapeutics on 2 of the 3 factors compared between the two stocks.How does Jasper Therapeutics compare to Aravive?Jasper Therapeutics (NASDAQ:JSPRW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings. Which has preferable earnings & valuation, JSPRW or ARAV? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/AN/AN/AN/AAraviveN/AN/AN/A-$0.90N/A Do insiders & institutionals hold more shares of JSPRW or ARAV? 35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor JSPRW or ARAV? In the previous week, Jasper Therapeutics had 4 more articles in the media than Aravive. MarketBeat recorded 4 mentions for Jasper Therapeutics and 0 mentions for Aravive. Aravive's average media sentiment score of 0.00 beat Jasper Therapeutics' score of -0.20 indicating that Aravive is being referred to more favorably in the news media. Company Overall Sentiment Jasper Therapeutics Neutral Aravive Neutral Is JSPRW or ARAV more profitable? Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A N/A N/A Aravive N/A N/A N/A SummaryAravive beats Jasper Therapeutics on 3 of the 4 factors compared between the two stocks.How does Jasper Therapeutics compare to Atlantic Coastal Acquisition Corp. II?Jasper Therapeutics (NASDAQ:JSPRW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings. Is JSPRW or ACABW more profitable? Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Which has stronger earnings and valuation, JSPRW or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A Does the media favor JSPRW or ACABW? In the previous week, Jasper Therapeutics had 4 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 4 mentions for Jasper Therapeutics and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 beat Jasper Therapeutics' score of -0.20 indicating that Atlantic Coastal Acquisition Corp. II is being referred to more favorably in the news media. Company Overall Sentiment Jasper Therapeutics Neutral Atlantic Coastal Acquisition Corp. II Neutral SummaryJasper Therapeutics and Atlantic Coastal Acquisition Corp. II tied by winning 1 of the 2 factors compared between the two stocks.How does Jasper Therapeutics compare to Avidity Biosciences?Jasper Therapeutics (NASDAQ:JSPRW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership. Which has preferable earnings and valuation, JSPRW or RNA? Jasper Therapeutics has higher earnings, but lower revenue than Avidity Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/AN/AN/AN/AAvidity Biosciences$36.68M6.04-$322.30MN/AN/A Do analysts recommend JSPRW or RNA? Avidity Biosciences has a consensus price target of $69.42, suggesting a potential upside of 436.07%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Avidity Biosciences is more favorable than Jasper Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jasper Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Avidity Biosciences 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.37 Is JSPRW or RNA more profitable? Jasper Therapeutics has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Jasper Therapeutics' return on equity of 0.00% beat Avidity Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A N/A N/A Avidity Biosciences -3,650.39%-44.92%-39.57% Does the media refer more to JSPRW or RNA? In the previous week, Avidity Biosciences had 1 more articles in the media than Jasper Therapeutics. MarketBeat recorded 5 mentions for Avidity Biosciences and 4 mentions for Jasper Therapeutics. Avidity Biosciences' average media sentiment score of 0.80 beat Jasper Therapeutics' score of -0.20 indicating that Avidity Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jasper Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Avidity Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAvidity Biosciences beats Jasper Therapeutics on 7 of the 10 factors compared between the two stocks. Get Jasper Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JSPRW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JSPRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JSPRW vs. The Competition ExportMetricJasper TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$465.73M$6.25B$12.23BDividend YieldN/A3.87%2.80%5.32%P/E RatioN/A3.7620.7925.05Price / SalesN/A7,435.94531.2172.69Price / CashN/A13.1343.0954.25Price / BookN/A83.539.816.83Net IncomeN/A-$96.07M$3.55B$335.69M7 Day PerformanceN/A0.52%-2.07%-2.03%1 Month PerformanceN/A0.18%-3.90%-1.90%1 Year PerformanceN/A71.17%29.39%27.36% Jasper Therapeutics Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JSPRWJasper TherapeuticsN/A$0.01-10.6%N/A-82.6%$0.00N/AN/A20Short Interest IncreaseAIMDWAinosN/A$0.10+3.0%N/A-54.3%$0.00$124.16KN/A40News CoverageALVOWAlvotechN/A$0.20flatN/A-87.9%$0.00$586.32MN/A4Gap UpARAVAraviveN/A$0.04flatN/AN/A$0.00N/AN/A20High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.00flatN/AN/A$0.00N/AN/A15 Related Companies and Tools Related Companies Ainos Competitors Alvotech Competitors Aravive Competitors Atlantic Coastal Acquisition Corp. II Competitors Avidity Biosciences Competitors Biofrontera Competitors Calithera Biosciences Competitors Celularity Competitors Cingulate Competitors Comera Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JSPRW) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
